These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16390237)

  • 1. Metastatic basal cell carcinoma: four case reports, review of literature, and immunohistochemical evaluation.
    Ionescu DN; Arida M; Jukic DM
    Arch Pathol Lab Med; 2006 Jan; 130(1):45-51. PubMed ID: 16390237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
    Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.
    Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP
    J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunomorphological features of cutaneous basal-cell carcinoma].
    Chuprov IN
    Vopr Onkol; 2008; 54(6):715-9. PubMed ID: 19241845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytologic diagnosis of metastatic basal cell carcinoma. Report of a case with immunocytochemical and molecular pathologic considerations.
    Giri DD; Gupta PK; Hoda RS
    Acta Cytol; 2000; 44(2):232-6. PubMed ID: 10740612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of PTCH1, COX-2, p53, and Ki-67 protein expression in basal cell carcinomas of nodular and superficial subtypes arising on the head and trunk.
    Khalesi M; Waterhouse M; Whiteman DC; Johns R; Rosendahl C; Hackett T; Pollak T; Kimlin MG; Hacker E; Neale RE;
    Int J Dermatol; 2016 Oct; 55(10):1096-105. PubMed ID: 27126210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
    Vidal D; Matías-Guiu X; Alomar A
    Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus.
    Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG
    Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis.
    Vidal D; Matías-Guiu X; Alomar A
    Br J Dermatol; 2004 Sep; 151(3):656-62. PubMed ID: 15377354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.
    Mateoiu C; Pirici A; Bogdan F
    Rom J Morphol Embryol; 2011; 52(1 Suppl):315-9. PubMed ID: 21424069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta and bcl-2 distribution patterns distinguish trichoepithelioma from basal cell carcinoma.
    Verhaegh ME; Arends JW; Majoie IM; Hoekzema R; Neumann HA
    Dermatol Surg; 1997 Aug; 23(8):695-700. PubMed ID: 9256917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis.
    Smith KJ; Williams J; Corbett D; Skelton H
    Am J Surg Pathol; 2001 Apr; 25(4):464-71. PubMed ID: 11257620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of bcl-2, p53 and Ki-67 in arsenical skin cancers.
    Chang CH; Tsai RK; Chen GS; Yu HS; Chai CY
    J Cutan Pathol; 1998 Oct; 25(9):457-62. PubMed ID: 9821074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trisomy 6 in basal cell carcinomas correlates with metastatic potential: a dual color fluorescence in situ hybridization study on paraffin sections.
    Nangia R; Sait SN; Block AW; Zhang PJ
    Cancer; 2001 May; 91(10):1927-32. PubMed ID: 11346875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant basal cell carcinoma associated with human papillomaviruses infection.
    Northington M; Tamburin L; Hamza S; Diwan H; Skelton H; Smith K
    J Cutan Pathol; 2004 Feb; 31(2):174-8. PubMed ID: 14690463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of p53 and Ki67 Expression Profiles in Basal Cell Carcinomas in a Usual and an Unusual Location.
    Süngü N; Kiran MM; Tatli Doğan H; Kiliçarslan A; Karakök E; Akyol M
    Turk Patoloji Derg; 2018; 34(2):165-170. PubMed ID: 29630084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p53 in arsenic-related and sporadic basal cell carcinoma.
    Boonchai W; Walsh M; Cummings M; Chenevix-Trench G
    Arch Dermatol; 2000 Feb; 136(2):195-8. PubMed ID: 10677095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of p53, Ki67, α-SMA, CD44 and CD31 in different histological subtypes of basal cell carcinoma.
    Cojocaru A; Bîrjovanu C; Ciurea AM; Niculescu D; Orzan OA; Ion A; Alexandru DO; Pirici I; Vîlcea EJ; Marinescu EA; Ciurea ME
    Rom J Morphol Embryol; 2022; 63(2):383-393. PubMed ID: 36374143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases.
    Batinac T; Zamolo G; Jonjić N; Gruber F; Petrovecki M
    Tumori; 2004; 90(1):120-7. PubMed ID: 15143984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.